Wall Street is positive on InspireMD Inc (NSPR). On average, analysts give NSPR a Strong Buy rating. The average price target is $2, which means analysts expect the stock to climb by 387.80% over the next twelve months.
That average ranking earns NSPR an Analyst Rating of 80, which is better than 80% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
Investors Observer combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With InspireMD Inc Stock Today?
InspireMD Inc (NSPR) stock is higher by 16.86% while the S&P 500 is down -1.48% as of 3:11 PM on Monday, Oct 19. NSPR has gained $0.06 from the previous closing price of $0.35 on volume of 8,180,844 shares. Over the past year the S&P 500 is higher by 14.15% while NSPR is down -65.25%. NSPR lost -$2.45 per share the over the last 12 months.